Faricimab – The Fight Against Retinal Diseases
Faricimab (Vabysmo) is the first approved bispecific antibody uniquely engineered to block two key pathways driving retinal vascular disease by…
Bayer’s Eylea 8mg Makes Huge Regulatory Strides Worldwide: Receives Approval in UK, Days After Japan; Application for Approval Accepted in China
Recent regulatory nods join a string of approvals including the United States and European Union German pharmaceutical giant Bayer announced…
latest posts
